FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2564303203> ?p ?o ?g. }

• W2564303203 endingPage "322" @default.
• W2564303203 startingPage "312" @default.
• W2564303203 abstract "Abstract Hepatocellular carcinoma, a deadly disease, commonly arises in the setting of chronic inflammation. C-C motif chemokine ligand 2 (CCL2/MCP1), a chemokine that recruits CCR2-positive immune cells to promote inflammation, is highly upregulated in hepatocellular carcinoma patients. Here, we examined the therapeutic efficacy of CCL2–CCR2 axis inhibitors against hepatitis and hepatocellular carcinoma in the miR-122 knockout (a.k.a. KO) mouse model. This mouse model displays upregulation of hepatic CCL2 expression, which correlates with hepatitis that progress to hepatocellular carcinoma with age. Therapeutic potential of CCL2–CCR2 axis blockade was determined by treating KO mice with a CCL2-neutralizing antibody (nAb). This immunotherapy suppressed chronic liver inflammation in these mice by reducing the population of CD11highGr1+ inflammatory myeloid cells and inhibiting expression of IL6 and TNFα in KO livers. Furthermore, treatment of tumor-bearing KO mice with CCL2 nAb for 8 weeks significantly reduced liver damage, hepatocellular carcinoma incidence, and tumor burden. Phospho-STAT3 (Y705) and c-MYC, the downstream targets of IL6, as well as NF-κB, the downstream target of TNFα, were downregulated upon CCL2 inhibition, which correlated with suppression of tumor growth. In addition, CCL2 nAb enhanced hepatic NK-cell cytotoxicity and IFNγ production, which is likely to contribute to the inhibition of tumorigenesis. Collectively, these results demonstrate that CCL2 immunotherapy could be an effective therapeutic approach against inflammatory liver disease and hepatocellular carcinoma. Mol Cancer Ther; 16(2); 312–22. ©2016 AACR." @default.
• W2564303203 created "2017-01-06" @default.
• W2564303203 creator A5009645785 @default.
• W2564303203 creator A5017098435 @default.
• W2564303203 creator A5024388674 @default.
• W2564303203 creator A5031494639 @default.
• W2564303203 creator A5038041285 @default.
• W2564303203 creator A5039958942 @default.
• W2564303203 creator A5049192022 @default.
• W2564303203 creator A5054228072 @default.
• W2564303203 creator A5059349957 @default.
• W2564303203 creator A5061124226 @default.
• W2564303203 creator A5064955096 @default.
• W2564303203 creator A5084279554 @default.
• W2564303203 creator A5085789230 @default.
• W2564303203 date "2017-02-01" @default.
• W2564303203 modified "2023-10-16" @default.
• W2564303203 title "Blocking the CCL2–CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model" @default.
• W2564303203 cites W134033052 @default.
• W2564303203 cites W1524930058 @default.
• W2564303203 cites W1537599002 @default.
• W2564303203 cites W1610995402 @default.
• W2564303203 cites W1758612015 @default.
• W2564303203 cites W1772986380 @default.
• W2564303203 cites W178461477 @default.
• W2564303203 cites W1863396492 @default.
• W2564303203 cites W1963904011 @default.
• W2564303203 cites W1969499266 @default.
• W2564303203 cites W1970848783 @default.
• W2564303203 cites W1971837077 @default.
• W2564303203 cites W1988995126 @default.
• W2564303203 cites W1994378435 @default.
• W2564303203 cites W2012034410 @default.
• W2564303203 cites W2019694067 @default.
• W2564303203 cites W2019953132 @default.
• W2564303203 cites W2022687771 @default.
• W2564303203 cites W2025767721 @default.
• W2564303203 cites W2026993656 @default.
• W2564303203 cites W2029426792 @default.
• W2564303203 cites W2038615253 @default.
• W2564303203 cites W2057650091 @default.
• W2564303203 cites W2066255007 @default.
• W2564303203 cites W2068127752 @default.
• W2564303203 cites W2080998956 @default.
• W2564303203 cites W2082668371 @default.
• W2564303203 cites W2088629624 @default.
• W2564303203 cites W2090054300 @default.
• W2564303203 cites W2090754742 @default.
• W2564303203 cites W2098236252 @default.
• W2564303203 cites W2099873826 @default.
• W2564303203 cites W2110385952 @default.
• W2564303203 cites W2114202720 @default.
• W2564303203 cites W2115991409 @default.
• W2564303203 cites W2116556497 @default.
• W2564303203 cites W2118278569 @default.
• W2564303203 cites W2141262236 @default.
• W2564303203 cites W2156758658 @default.
• W2564303203 cites W2172011549 @default.
• W2564303203 cites W2173632235 @default.
• W2564303203 cites W2194546364 @default.
• W2564303203 cites W2272222114 @default.
• W2564303203 cites W2413293685 @default.
• W2564303203 cites W37117207 @default.
• W2564303203 cites W4245403358 @default.
• W2564303203 doi "https://doi.org/10.1158/1535-7163.mct-16-0124" @default.
• W2564303203 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5292068" @default.
• W2564303203 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27980102" @default.
• W2564303203 hasPublicationYear "2017" @default.
• W2564303203 type Work @default.
• W2564303203 sameAs 2564303203 @default.
• W2564303203 citedByCount "90" @default.
• W2564303203 countsByYear W25643032032017 @default.
• W2564303203 countsByYear W25643032032018 @default.
• W2564303203 countsByYear W25643032032019 @default.
• W2564303203 countsByYear W25643032032020 @default.
• W2564303203 countsByYear W25643032032021 @default.
• W2564303203 countsByYear W25643032032022 @default.
• W2564303203 countsByYear W25643032032023 @default.
• W2564303203 crossrefType "journal-article" @default.
• W2564303203 hasAuthorship W2564303203A5009645785 @default.
• W2564303203 hasAuthorship W2564303203A5017098435 @default.
• W2564303203 hasAuthorship W2564303203A5024388674 @default.
• W2564303203 hasAuthorship W2564303203A5031494639 @default.
• W2564303203 hasAuthorship W2564303203A5038041285 @default.
• W2564303203 hasAuthorship W2564303203A5039958942 @default.
• W2564303203 hasAuthorship W2564303203A5049192022 @default.
• W2564303203 hasAuthorship W2564303203A5054228072 @default.
• W2564303203 hasAuthorship W2564303203A5059349957 @default.
• W2564303203 hasAuthorship W2564303203A5061124226 @default.
• W2564303203 hasAuthorship W2564303203A5064955096 @default.
• W2564303203 hasAuthorship W2564303203A5084279554 @default.
• W2564303203 hasAuthorship W2564303203A5085789230 @default.
• W2564303203 hasBestOaLocation W25643032031 @default.
• W2564303203 hasConcept C101666144 @default.
• W2564303203 hasConcept C121608353 @default.
• W2564303203 hasConcept C126322002 @default.
• W2564303203 hasConcept C12823836 @default.
• W2564303203 hasConcept C13373296 @default.

• next